Leah Schnurr, Reuters
Euro zone worries pressure Wall St
NEW YORK (Reuters) – Stocks dipped on Monday with investors taking profits and looking for further action from European officials to prevent a debt crisis from spreading.
Euro zone finance ministers were set to meet amid pressure to increase the size of a 750 billion euro ($1,006 billion) safety net for debt-stricken members. But Germany rejected any such move.
“Even if Germany gets on board, does Germany become the benefactor of all of Europe?” said Nick Kalivas, senior equity index analyst at MF Global in Chicago. “Is it politically and economically viable for the euro?”
The euro fell, pressuring equities. Stocks and the euro have moved in tandem of late, with the euro looked at as a proxy for debt concerns.
Yesterday's Top Performing Small Cap Stock:
Tootie Pie Company TOOT
Tootie Pie Company was a SmallCapVoice.com top performer closing up over 8% on trading volume of 25,843 shares.
Tootie Pie Company bakes and sells high-quality, handmade pies through three basic sales channels: retail, corporate and wholesale. The retail segment serves individual consumers through in-store sales, orders via telephone and internet on the Company's website. The corporate segment serves businesses that purchase pies as a way to promote their company through client and employee appreciation programs. The wholesale segment is made up of national and regional broad line grocery and foodservice distributors who purchase pies and then resell them through their respective sales distribution channels.
Today's SmallCapVoice.com Hot Stock to Watch:
Madison Ave. Media, Inc. KHZM
Madison Ave. Media is an advanced digital media company that offers a differentiated and competitive array of marketing technologies and services to clients in multiple industries. Their technology and services bring advanced, highly productive marketing, communications and advertising solutions to clients. And their services address the complete digital media value chain, combining the best practices of traditional media support with the power of technology.
Other Small Cap News
Vicon Industries, Inc. (NYSE Amex: VII)
Vicon Reports Fourth Quarter and Fiscal Year 2010 Results
HAUPPAUGE, N.Y.–(BUSINESS WIRE)– Vicon Industries, Inc. (NYSE-AMEX: VII), a leading designer and producer of video security and surveillance systems, today reported operating results for the fourth fiscal quarter and year ended September 30, 2010. The announcement was made by Chairman and CEO Ken Darby, who said, “The fourth quarter and full year results reflect a continuing weak capital spending environment in all our primary markets worldwide.”
Retractable Technologies, Inc. (NYSE Amex: RVP)
Retractable Technologies, Inc. Reports 77% Gross Profit Increase for Q3 2010
LITTLE ELM, Texas–(BUSINESS WIRE)– Retractable Technologies, Inc. (“Retractable”) (NYSE AMEX: RVP), a leading maker of safety medical devices, reported a gross profit of $5.2 million for the three months ended September 30, 2010, a 77.1% increase over its gross profit for the three months ended September 30, 2009. Retractable also reported a gross profit of more than $11.4 million for the nine months ended September 30, 2010, a 76.4% increase over the nine months ended September 30, 2009.
Hill International, Inc. HIL
Hill International Agrees to Acquire Majority Stake in Brazil's Engineering S.A.
MARLTON, N.J. and RIO DE JANEIRO, Brazil, Dec. 3, 2010 (GLOBE NEWSWIRE) — Hill International HIL, the global leader in managing construction risk, announced today that its Madrid-based subsidiary Gerens Hill International S.A. has entered into a definitive agreement to acquire 60% of the outstanding capital stock of Engineering S.A., one of the largest project management firms in Brazil with approximately 500 professionals. Terms of the transaction were not disclosed. “Engineering S.A. and Hill International are cooperati
Keryx Biopharmaceuticals, Inc. KERX
Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
NEW YORK, Dec. 6, 2010 /PRNewswire-FirstCall/ — Keryx Biopharmaceuticals, Inc. KERX today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Aeterna Zentaris Inc. AEZS
Aeterna Zentaris: Phase 2 Data Demonstrate Perifosine's Promising Efficacy in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
QUÉBEC CITY, Dec. 6 /PRNewswire/ – Aeterna Zentaris Inc. AEZS today announced Phase 2 data presented for the first time on perifosine, its lead novel oral anti-cancer compound, showing promising clinical activity, safety and tolerability in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). The data were presented over the weekend at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida.
Immunomedics, Inc. IMMU
First Results From Phase II Study of Fractionated Radioimmunotherapy With Y-90 Epratuzumab in Aggressive Lymphoma Presented at Hematology Conference
Preclinical Results of IMMU-114 for Prevention and Treatment of Graft-Versus-Host Disease Also Reported
ORLANDO, Fla., Dec. 6, 2010 (GLOBE NEWSWIRE) — Immunomedics, Inc. IMMU, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma. These results were presented by the French GOELAMS group at the 52nd annual meeting of the American Society of Hematology (ASH).
Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD)
Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares
DETROIT, Dec. 6, 2010 /PRNewswire-FirstCall/ — Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) reports receipt of a proposal from Sun Pharmaceutical Industries Ltd. (“Sun”) and Sun Pharma Global, Inc (“Sun Global”) for a going private transaction by which Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not held by Sun or Sun Global for a per share consideration of $4.75 in cash. This represents a 5% premium over the closing price of Caraco Common Stock on Dec 2, 2010.
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.
The SmallCapVoice.com, Inc. Daily Highlights is an electronic publication, and is for informational purposes only. The Small Cap Voice Daily Highlights covers both client and non client issuers. Non client issuer's news is listed under other small cap news. SmallCapVoice is an electronic publication providing information on selected public companies. All companies profiled on this website pay cash or restricted stock to SmallCapVoice as consideration for the electronic dissemination of the company's information and our comments about the company. Section 17(b) of the Securities Act of 1933 requires that SmallCapVoice fully disclose the type consideration (i.e. cash, restricted stock, and restricted stock with registration rights, stock options, stock warrants, or other type consideration) and the specific amount of the consideration our company receives or will receive, directly or indirectly, from an issuer, underwriter, or dealer. No information contained in our website, e-mail communications or our publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. SmallCapVoice is not a registered investment advisor or a registered securities broker dealer. We do not undertake or represent to make investment recommendations or to give advice pertaining to the purchase or sale of the securities mentioned in our web site, e-mail communications or publications. The information contained in our website, e-mail communications and publications are carefully compiled by SmallCapVoice from public sources that we believe to be reliable. SmallCapVoice, however, does not guarantee the accuracy of any information contained in our website, e-mail communications or publications. This material is not a substitute for either one's own thorough investigation of an investment opportunity or the exercise of good business judgment. SmallCapVoice does not endorse, independently verify, or assert the truthfulness or reliability of any statements or data obtained from third party sources that are published by us about the profiled companies in our website articles, e-mail communications or publications, but we do not publish information that we know is incorrect. Investors should not rely solely on the information contained in our website, e-mail communications or publications when making investment decisions. Instead, investors should use the information provided on the profiled companies as a starting point for conducting additional research that will permit them to form their own opinions regarding the appropriateness of an investment in the profiled company's securities. SmallCapVoice does not warrant, represent or guaranty that there has been no change in the affairs of the profiled company since the date that information was published on this website, in e-mail communications or in our publications regarding a profiled company or after the date of the profiled company's press releases or other information disseminated via our website or publications. If you become aware of any change of circumstances related to any website article, e-mail communication or publication, please notify us immediately. See the Contact Us page for the appropriate e-mail address. The information contained in our website, e-mail communications and publications pertains to microcap, small cap and/or other thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these type of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities. SmallCapVoice may liquidate the stock consideration it receives at any time it deems it appropriate to do so after the required six-month holding period has run after the completion of the services for which SmallCapVoice was paid in stock. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company's securities. The following companies have paid, and/or have agreed to pay SmallCapVoice to: distribute the company's information and reports on this website, to send e-mail communications; to send publications by mail, to post company Internet links on our website, and to compile and/or to distribute reports in an e-mail newsletter.
We encourage our readers to use caution when investing and educate themselves at the web sites of the Securities and Exchange Commission (“SEC”) at www.sec.gov and/or the National Association of Securities Dealers (“NASD”) at www.nasd.com. We encourage you to study the SEC's policies regarding online newsletters at http://www.sec.gov/answers/newsltr.htm. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our site.
Contact:
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com
Related posts
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
